For more than three decades, researchers studying genomes have relied on foundational resources such as Repbase and, more ...

Genome editing lets scientists rewrite DNA, the instruction manual inside every living cell, with a precision that was unthinkable a generation ago. Technologies such as CRISPR have made this almost ...

Since April 10, the iShares Expanded Tech-Software Sector ETF (IGV) has rallied 36% and reclaimed its 200-day moving average, signaling a return to a long-term uptrend despite earlier concerns over AI ...

The rally in software stocks has gone from recovery to raging bull market, and traders are betting there's more to come. The iShares Expanded Tech-Software ETF (IGV) is up 35% from its April low after ...

The Investment Committee give you their top stocks to watch for the second half. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your ...

J. Craig Venter, the scientist who raced to decode the human genome, has died at age 79. Venter rose to fame in the field for publishing the first bacterial genome ever decoded, along with a list of ...

The iShares Expanded Tech-Software Sector ETF (IGV) cratered more than 24% in Q1 2026, its worst quarterly plunge since Q4 2008, erasing gains and dragging software names into bear territory amid AI ...

Samsung Internet Browser, previously exclusive to Android devices, is now fully available on Windows as a Chromium-based alternative to Chrome and Edge. PCWorld reports the browser offers Galaxy AI ...

Fidelity MSCI Information Technology ETF (NYSEARCA:FTEC) tracks the MSCI USA IMI Information Technology Index, giving investors exposure to the full breadth of U.S. technology — from chip designers ...

One of the more volatile tech funds, the iShares Expanded Tech-Software Sector ETF (NYSEARCA:IGV) has bounced 5.13% over the past week, reversing after a collapse that left the fund down 18% ...